Breaking News Instant updates and real-time market news.

ATRA

Atara Biotherapeutics

$43.10

-0.9 (-2.05%)

07:14
02/27/18
02/27
07:14
02/27/18
07:14

Atara Biotherapeutics reports Q4 EPS ($1.15), consensus ($1.14)

Cash, cash equivalents and short-term investments as of December 31, 2017 totaled $166.1M, which the company believes, along with the $131.4M net proceeds from the sale of 7,675,072 shares of common stock in an underwritten public offering completed in January 2018, will be sufficient to fund planned operations into the first half of 2020.

  • 04

    Apr

ATRA Atara Biotherapeutics
$43.10

-0.9 (-2.05%)

01/26/18
01/26/18
INITIATION

On The Fly: Top five analyst initiations
Catch up on today's top five analyst initiations with this list compiled by The Fly: 1. Williams Scotsman (WSC) initiated with an Outperform at Oppenheimer. 2. RedHill Biopharma (RDHL) initiated with a Buy at Nomura Instinet. 3. BioDelivery Sciences (BDSI) initiated with a Buy at Seaport Global. 4. NuStar GP Holdings (NSH) initiated with a Buy at B. Riley FBR. 5. Atara Biotherapeutics (ATRA) initiated with an Outperform at Cowen. This list is just a portion of The Fly's analyst coverage. To see The Fly's full Street Research coverage, click here.
01/30/18
ADAM
01/30/18
NO CHANGE
Target $70
ADAM
Buy
Atara Biotherapeutics enterprise value underappreciated, says Canaccord
Canaccord analyst John Newman compared Atara Biotherapeutics to competitors and believes its enterprise value is being underappreciated by the market. Newman reiterates his Buy rating on Atara on expectations of Phase 3 success of its lead drug candidate and keeps a $70 price target on the shares.
02/15/18
SBSH
02/15/18
DOWNGRADE
Target $25
SBSH
Sell
Atara Biotherapeutics downgraded to Sell from Neutral at Citi
Citi analyst Yigal Nochomovitz downgraded Atara Biotherapeutics to Sell while raising his price target for the shares to $25 from $18. The recent 200%-plus rally in the shares is not supported by fundamentals, Nochomovitz tells investors in a research note. He believes Atara is "being swept into the M&A play driven by the CAR-T names" and notes the company is not a CAR-T play. The analyst says he hasn't seen new data or other de-risking events to support the valuation re-rating.
02/15/18
02/15/18
DOWNGRADE

On The Fly: Top five analyst downgrades
Catch up on today's top five analyst downgrades with this list compiled by The Fly: 1. Alaska Air (ALK) downgraded to Neutral from Buy at UBS with analyst Darryl Genovesi saying he believes consensus estimates are too high and in particular reflect too rosy a RASM view given progressively more intense competition in its network. 2. Patterson Companies (PDCO) downgraded to Underweight from Neutral at JPMorgan with analyst Michael Minchak saying the company faces more near-term headwinds and uncertainties relative to other names he covers. He believes it will take time for Patterson's initiatives to bear fruit. 3. Cemex (CX) downgraded to Sell from Buy at UBS with analyst Mauricio Serna says he expects the share selloff to continue given the company's "struggling" international operations and "still high" debt. 4. Atara Biotherapeutics (ATRA) downgraded to Sell from Neutral at Citi with analyst Yigal Nochomovitz saying the recent 200%-plus rally in the shares is not supported by fundamentals. 5. Tanger Factory (SKT) downgraded to Underperform from In Line at Evercore ISI. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.

TODAY'S FREE FLY STORIES

BV

BrightView

$21.95

0.14 (0.64%)

05:29
07/23/18
07/23
05:29
07/23/18
05:29
Initiation
BrightView initiated  »

BrightView initiated with…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SGMO

Sangamo

$15.10

0.025 (0.17%)

05:28
07/23/18
07/23
05:28
07/23/18
05:28
Hot Stocks
Sangamo to acquire TxCell for EUR 2.58 per share in cash »

Sangamo Therapeutics and…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BV

BrightView

$21.95

0.14 (0.64%)

05:27
07/23/18
07/23
05:27
07/23/18
05:27
Initiation
BrightView initiated  »

BrightView initiated with…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

HCM

Hutchison China MediTech

$33.92

0.89 (2.69%)

05:25
07/23/18
07/23
05:25
07/23/18
05:25
Hot Stocks
Chi-Med initiates Phase Ib/II proof-of-concept study of sulfatib »

Hutchison China MediTech,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Jul

BJ

BJ's Wholesale

$25.90

0.23 (0.90%)

05:23
07/23/18
07/23
05:23
07/23/18
05:23
Initiation
BJ's Wholesale initiated  »

BJ's Wholesale…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

RHHBY

Roche

$0.00

(0.00%)

05:22
07/23/18
07/23
05:22
07/23/18
05:22
Hot Stocks
Roche receives CE Mark for Accu-Chek Solo micropump system »

Roche announced that it…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 08

    Aug

PZZA

Papa John's

$51.61

0.62 (1.22%)

05:22
07/23/18
07/23
05:22
07/23/18
05:22
Hot Stocks
Papa John's adopts limited duration stockholder rights plan »

Papa John's…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SPX

S&P 500

$0.00

(0.00%)

, SPY

SPDR S&P 500 ETF Trust

$279.71

-0.24 (-0.09%)

05:21
07/23/18
07/23
05:21
07/23/18
05:21
General news
Trump tells Iranian President to 'never, ever threaten' U.S. again »

President Trump tweeted…

SPX

S&P 500

$0.00

(0.00%)

SPY

SPDR S&P 500 ETF Trust

$279.71

-0.24 (-0.09%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

STIM

Neuronetics

$26.27

-0.44 (-1.65%)

05:19
07/23/18
07/23
05:19
07/23/18
05:19
Initiation
Neuronetics initiated  »

Neuronetics initiated…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

PZZA

Papa John's

$51.61

0.62 (1.22%)

05:17
07/23/18
07/23
05:17
07/23/18
05:17
Downgrade
Papa John's rating change  »

Papa John's…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ACN

Accenture

$166.47

-0.47 (-0.28%)

05:16
07/23/18
07/23
05:16
07/23/18
05:16
Hot Stocks
Accenture forms strategic alliance with Ripjar, terms not disclosed »

Accenture has formed a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 30

    Jul

  • 06

    Aug

BV

BrightView

$21.95

0.14 (0.64%)

05:12
07/23/18
07/23
05:12
07/23/18
05:12
Initiation
BrightView initiated  »

BrightView initiated with…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TCDA

Tricida

$29.50

-0.42 (-1.40%)

05:10
07/23/18
07/23
05:10
07/23/18
05:10
Initiation
Tricida initiated  »

Tricida initiated with a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BV

BrightView

$21.95

0.14 (0.64%)

05:08
07/23/18
07/23
05:08
07/23/18
05:08
Initiation
BrightView initiated  »

BrightView initiated with…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

INSM

Insmed

$24.98

-0.12 (-0.48%)

05:07
07/23/18
07/23
05:07
07/23/18
05:07
Initiation
Insmed initiated  »

Insmed initiated with a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 07

    Aug

  • 28

    Sep

BJ

BJ's Wholesale

$25.90

0.23 (0.90%)

05:04
07/23/18
07/23
05:04
07/23/18
05:04
Initiation
BJ's Wholesale initiated  »

BJ's Wholesale…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BJ

BJ's Wholesale

$25.90

0.23 (0.90%)

05:01
07/23/18
07/23
05:01
07/23/18
05:01
Initiation
BJ's Wholesale initiated  »

BJ's Wholesale…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

DUK

Duke Energy

$80.64

-0.56 (-0.69%)

04:58
07/23/18
07/23
04:58
07/23/18
04:58
Upgrade
Duke Energy rating change  »

Duke Energy upgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 02

    Aug

STI

SunTrust

$70.86

1.855 (2.69%)

04:55
07/23/18
07/23
04:55
07/23/18
04:55
Upgrade
SunTrust rating change  »

SunTrust upgraded to Buy…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

04:55
07/23/18
07/23
04:55
07/23/18
04:55
Conference/Events
RBC Capital commodity strategist to hold a dinner meeting »

Commodity Strategist…

MGEN

Miragen Therapeutics

$6.87

-0.08 (-1.15%)

04:55
07/23/18
07/23
04:55
07/23/18
04:55
Conference/Events
Miragen Therapeutics management to meet with Oppenheimer »

Meeting to be held in New…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Jul

04:55
07/23/18
07/23
04:55
07/23/18
04:55
General news
Breaking General news story  »

6-Month Bill Auction to…

SAR

Saratoga Investment

$24.59

0.08 (0.33%)

04:55
07/23/18
07/23
04:55
07/23/18
04:55
Conference/Events
Saratoga Investment management to meet with Compass Point »

Meeting to be held in New…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Jul

04:55
07/23/18
07/23
04:55
07/23/18
04:55
General news
Breaking General news story  »

3-Month Bill Auction to…

NTEC

Intec Pharma

$4.75

(0.00%)

04:55
07/23/18
07/23
04:55
07/23/18
04:55
Conference/Events
Intec Pharma management to meet with Oppenheimer »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Jul

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.